Arecor continue to make significant strides proving the strength of their technology.
Scancell continue progress for Modi-2 by in-licencing Vaccitech technology.
Arecor’s subsidiary launch a new treatment option for severe hypoglycaemia for children and adults living with diabetes.
Elizabeth Klein joins Calculus as a Director within the investment team, bringing a wealth of experience.
Scancell said it has enrolled its first patient in the expansion phase of its ModiFY trial.
Welcome to our third quarterly update of 2022. This quarter, we are delighted to announce the launch of our HMRC approved Knowledge Intensive EIS Fund, whereby investors in the Fund can take advantage of full tax relief in this tax year (or carry back to 2021/22) making tax planning simpler than ever. The Calculus Knowledge … Continued
Riff Raff Entertainment update on latest project and Brouhaha release first look of ‘Lee’.
We are updating our terms Please review this notice and the updated terms below in their entirety to familiarise yourself with the upcoming changes. These updated terms will be effective and binding as of October 2022. No further action is required on your part. If you have any questions, please don’t hesitate to get in touch: … Continued
Scancell Holdings, Calculus portfolio company, said it has signed a deal worth up to US$208m.
As UK Inflation hits 10.1% John Glencross, CEO of Calculus, Shares his views on the implications.